Home/Filings/4/0001171843-25-008037
4//SEC Filing

Barnes Alane P 4

Accession 0001171843-25-008037

CIK 0000882796other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 4:17 PM ET

Size

15.3 KB

Accession

0001171843-25-008037

Insider Transaction Report

Form 4
Period: 2025-12-17
Barnes Alane P
VP, General Counsel & Corp Sec
Transactions
  • Award

    Common Stock

    2025-12-17+121,700437,426 total
  • Award

    Emp. Stock Option (Right to Buy)

    2025-12-17+255,050255,050 total
    Exercise: $7.13From: 2026-12-17Exp: 2035-12-17Common Stock (255,050 underlying)
Footnotes (2)
  • [F1]Annual award of restricted stock units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
  • [F2]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001584348

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:17 PM ET
Size
15.3 KB